48
Views
8
CrossRef citations to date
0
Altmetric
Original Article

A Prospective Randomized Study of Chop Versus Chop Plus Alpha-2B Interferon in Patients with Intermediate and High Grade Non-Hodgkin's Lymphoma: The International Oncology Study Group NHL1 Study

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 95-103 | Received 10 Apr 2000, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gerassimos A. Pangalis, Theodoros P. Vassilakopoulos, Evridiki Michalis, Paraskevi Roussou, Effimia Vrakidou, Panayiotis Repousis, Maria K. Angelopoulou, Marina P. Siakantaris, John Korantzis, Argyrios Symeonidis, Vassiliki Grigorakis, Ekaterini Stefanoudakis, Marina Stamatellou, Konstantinos L. Bourantas, Themis Kalmantis, George Christopoulos, Garyfallia Kokkinis, Ilias Mihalakeas & Antonios Papayiannis. (2003) A Randomized Trial Comparing Intensified CNOP vs. CHOP in Patients with Aggressive Non-Hodgkin's Lymphoma. Leukemia & Lymphoma 44:4, pages 635-644.
Read now

Articles from other publishers (7)

Marijke Linschoten, Janine A M Kamphuis, Anna van Rhenen, Laurens P Bosman, Maarten J Cramer, Pieter A Doevendans, Arco J Teske & Folkert W Asselbergs. (2020) Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis. The Lancet Haematology 7:4, pages e295-e308.
Crossref
Guven Cetin, Elif Ece Dogan, Nilay Sengul Samanci, Mesut Ayer, Tuba Ozkan, Iskender Ekinci, Rabia Bag, Seda Turgut & Omer Uysal. (2019) Treatment modalities of non-Hodgkin lymphoma patients over 65 years of age: A two-center experience. Journal of Oncology Pharmacy Practice 26:1, pages 99-104.
Crossref
L. Lee, L. Wang & M. Crump. (2011) Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points. Annals of Oncology 22:6, pages 1392-1403.
Crossref
Robert O. Dillman. (2011) Cancer Immunotherapy. Cancer Biotherapy and Radiopharmaceuticals 26:1, pages 1-64.
Crossref
Paolo Baldo, Maurizio Rupolo, Anna Compagnoni, Renzo Lazzarini, Alessandra Bearz, Renato Cannizzaro, Simon Spazzapan, Ivana Truccolo & Lorenzo Moja. (2010) Interferon-alpha for maintenance of follicular lymphoma. Cochrane Database of Systematic Reviews.
Crossref
Ronald Mihelic, Jonathan Kaufman, Sagar Lonial & Christopher Flowers. (2007) Maintenance Therapy in Lymphoma. Clinical Lymphoma and Myeloma 7:8, pages 507-513.
Crossref
. (2001) Current Awareness. Hematological Oncology 19:3, pages 121-128.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.